Condition: Prostate Cancer · Sponsor: Hamilton Health Sciences Corporation
GAIN PC CONTROL is a study investigating Glucagon-Like Peptide-1 Receptor Agonists in men with prostate cancer who are being treated with androgen deprivation therapy.
This description comes directly from the study's public registry record.
Sarah Karampatos, BASc, MSc · 905-296-5795 · sarah.karampatos@phri.ca
Steven Agapay, BSc · 905-296-5764 · steve.agapay@phri.ca
Always discuss trial participation with your own doctor first.
| Juravinski Cancer Centre | Hamilton, Ontario, Canada | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06908694